The global Veterinary Vaccines Market, valued at USD 8.93 billion in 2023, is projected to grow at a CAGR of 6.1%, reaching USD 9.39 billion in 2024 and USD 13.33 billion by 2029, according to MarketsandMarkets.
The market’s expansion is fueled by increasing pet ownership, growth in the companion animal population, rising incidence of zoonotic diseases, and strong government initiatives to safeguard animal health. However, the high cost of vaccines remains a limiting factor for wider adoption, especially in price-sensitive regions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233
Key Market Drivers
- Companion Animal Growth – The surge in pet ownership, particularly dogs and cats, is boosting demand for vaccines that prevent common and emerging diseases.
- Zoonotic Disease Control – With increasing public health risks from animal-to-human diseases, vaccination programs have become a top priority worldwide.
- Government Initiatives – Programs focused on livestock vaccination for food safety, productivity improvement, and trade compliance are fueling demand.
- Rising Demand for Animal-Derived Food – As meat, milk, and dairy consumption rises globally, maintaining livestock health is critical to ensuring food supply chain resilience.
Market Insights by Segment
By Type
- Livestock vaccines held the largest share in 2023.
- Growing global demand for meat and dairy is driving preventive vaccination programs in cattle, swine, and poultry.
By Disease
- The livestock disease segment leads the market, reflecting the urgent need to manage disease outbreaks, ensure food safety, and protect economies reliant on livestock exports.
By Technology
- Live attenuated vaccines accounted for the largest share in 2023.
- These vaccines provide long-term immunity, are cost-effective, and remain widely adopted for livestock disease prevention.
By Region
- Asia Pacific emerged as the fastest-growing regional market in 2023.
- Rapid livestock industry expansion, increasing outbreaks of animal diseases, and stronger government intervention to improve animal health are driving regional growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233
Competitive Landscape
The veterinary vaccines market is highly competitive and innovation-driven. Key players focus on R&D, strategic partnerships, acquisitions, and regional expansions to strengthen their presence.
Major Companies:
- Zoetis (US) – Leading in vaccines, diagnostics, and animal health solutions with USD 614M R&D spend in 2023.
- Merck & Co., Inc. (US) – Expanding globally through acquisitions and agreements in animal health.
- Boehringer Ingelheim (Germany) – Strong presence with 4 billion vaccine doses sold in 2023.
- Elanco (US), Virbac (France), Ceva (France), HIPRA (Spain) – Innovating in livestock and companion animal vaccine portfolios.
- Emerging Players in Asia-Pacific – Companies such as Hester Biosciences (India), Tianjin Ringpu Biotechnology (China), and Jinyu Biotechnology (China) are gaining traction in local and export markets.
Outlook: Veterinary Vaccines as a Safeguard for Food Security and Public Health
The veterinary vaccines industry sits at the intersection of animal health, food security, and public health. With zoonotic disease prevention and safe animal-derived food production gaining global importance, the adoption of advanced vaccine technologies is set to accelerate.
As governments, livestock farmers, and pet owners increasingly recognize the economic and health value of preventive vaccination, the market will continue to see strong growth through 2029.
For more information, Inquire Now!